Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: (−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Fig. 6

Transport of EGCG and compound 3 across Caco-2 monolayers. a The transepithelial transport rate of EGCG and compound 3 (both 50 μg/mL) in the apical to basolateral direction. b The transepithelial transport rate of EGCG and compound 3 (both 50 μg/mL) in the basolateral to apical direction. c TEER values of Caco-2 monolayers (Ω cm2). Data represent mean ± SD (n = 3). ***p < 0.001 compound 3 vs EGCG

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us